• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Special Reports
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Resources
    • About MassDevice
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices
    • In-Depth Coverage
    • Latest News
  • Attend DeviceTalks
    • Events
      • DeviceTalks Minnesota – May 4
      • DeviceTalks Boston – May 27–28
      • DeviceTalks West
      • DeviceTalks Tuesdays
    • DeviceTalks Podcast Network
      • DeviceTalks Weekly
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Advertise
  • Subscribe

Vascular

MMI grasps $125M to support robotic microsurgery system

October 8, 2026 By Conor Hale

Medical Microinstruments raised $125 million in venture capital funding to extend its commercial operations and chase new indications and accessories for its Symani robotic surgery platform. MMI said it currently counts about 50 installed systems and 3,500 microsurgery procedures completed worldwide. Symani, which received a de novo clearance from the FDA in 2024, delivers fully […]

Filed Under: Business/Financial News, Featured, Robotic-Assisted, Surgical, Surgical Robotics, Vascular Tagged With: BioStar Capital, Medical Microinstruments, venture capital

J&J delivers Shockwave data sustaining below-the-knee gains for two years

October 7, 2026 By Conor Hale

Johnson & Johnson MedTech (NYSE: JNJ) shared extended clinical findings from its Shockwave intravascular lithotripsy system, from a study aimed at clearing calcified vessel blockages below the knee in patients with peripheral artery disease. In late-breaking data presented at the Vascular InterVentional Advances 2026 conference in Las Vegas, the company showed that benefits were maintained […]

Filed Under: Cardiovascular, Catheters, Vascular Tagged With: intravascular lithotripsy (IVL), Johnson & Johnson, Johnson & Johnson MedTech, Shockwave Medical, Vascular Interventional Advances (VIVA)

Mendaera rolls out handheld needle robot paired with Butterfly ultrasound probe

October 2, 2026 By Conor Hale

Mendaera announced its handheld robot for needle-based procedures is now available to pair with Butterfly Network’s (NYSE:BFLY) portable, chip-based ultrasound probe, following the companies’ long-running collaboration. The Focalist robotic image-guided system assists clinicians in aiming to place IV lines, deliver nerve blocks or otherwise access organs and vasculature without additional specialized training. After FDA clearance in July […]

Filed Under: Business/Financial News, Cardiovascular, Catheters, Featured, Imaging, Ultrasound, Urology, Vascular Tagged With: Butterfly Network, Mendaera

Medtronic snags breakthrough designation for below-the-knee drug-coated balloon

October 1, 2026 By Conor Hale

Medtronic (NYSE:MDT) has secured a breakthrough designation from the FDA for a version of its drug-coated balloon aimed at unblocking arteries below the knee, following years of development. The In.Pact BTK catheter is slated for an international, randomized pivotal trial that plans to enroll about 400 participants with peripheral artery disease in the lower legs, […]

Filed Under: Cardiovascular, Catheters, Featured, Hospital Care, Regulatory/Compliance, Vascular Tagged With: Drug-Eluting Balloons, Medtronic, peripheral artery disease

Terumo to buy Arsenal Medical and its liquid embolic brain bleed system

September 30, 2026 By Conor Hale

Terumo has inked a deal for its neurovascular subsidiary to acquire Arsenal Medical and its liquid embolic approach for treating certain brain bleeds. Arsenal’s investigational NeoCast is being developed for chronic and subacute subdural hematoma, through the blocking of the brain’s middle meningeal artery, or MMA. Terumo Neuro describes the solvent-free, non-adhesive biomaterial as a […]

Filed Under: Business/Financial News, Cardiovascular, Mergers & Acquisitions, Neurological, Vascular Tagged With: acquisitions, Arsenal Medical, mergers, Neurovascular, Terumo, Terumo Neuro

Perfuze’s super-bore stroke catheter tops conventional, cyclic aspiration in bench study

September 24, 2026 By Conor Hale

Following FDA clearance earlier this year, Perfuze is putting forward new data comparing its super-bore aspiration catheter to conventional suction methods for removing stroke-causing blood clots, as well as the emerging approach of cyclic aspiration. The three-way benchtop study of the company’s Millipede88 catheter, tested with in vitro models of large vessel occlusions, was described […]

Filed Under: Business/Financial News, Cardiovascular, Catheters, Featured, Neurological, Regulatory/Compliance, Research & Development, Vascular Tagged With: catheter, Neurovascular, Perfuze, Stroke

Cordis earns FDA nod for Selution SLR drug-eluting balloon

September 21, 2026 By Skyler Rivera

Cordis earned FDA approval for its Selution SLR (sustained limus release) drug-eluting balloon (DEB) to treat coronary in-stent restenosis, the device developer announced today. “As the first and only sirolimus drug-eluting balloon approved in the United States, Selution SLR  DEB introduces a groundbreaking therapy for the treatment of coronary in-stent restenosis.” Cordis President of Americas […]

Filed Under: Biotech, Business/Financial News, Cardiovascular, Catheters, Clinical Trials, Drug-Device Combinations, Drug-Eluting Stents, Featured, Food & Drug Administration (FDA), News Well, Pre-Market Approval (PMA), Regulatory/Compliance, Structural Heart, Structural Heart, Surgical, Vascular Tagged With: Cordis, drug delivery, Drug-Eluting Balloons, FDA

Boston Scientific recalls, discontinues angiographic catheter sales

September 2, 2026 By Skyler Rivera

Boston Scientific recalled and discontinued all Imager II angiographic catheters due to a manufacturing issue, according to an FDA early alert. Imager II angiographic catheters are diagnostic intravascular catheters used to capture images of the patient’s peripheral vasculature. Boston Scientific determined the catheters were “manufactured with reduced levels of stabilizing agents in the tips,” according […]

Filed Under: Business/Financial News, Catheters, Diagnostics, Featured, Food & Drug Administration (FDA), News Well, Recalls, Regulatory/Compliance, Vascular Tagged With: Boston Scientific, catheter, recall

J&J MedTech is rebranding Shockwave Medical

September 1, 2026 By Jim Hammerand

Johnson & Johnson plans to rebrand Shockwave Medical on Oct. 1, the device and drug developer said. “Shockwave Medical will be rebranded to Johnson & Johnson MedTech, and our technologies will be known as circulatory restoration solutions,” Shockwave said on LinkedIn today. “Although our name and color may be changing, our commitment to cardiovascular innovation […]

Filed Under: Cardiovascular, Featured, Mergers & Acquisitions, News Well, Vascular Tagged With: Johnson & Johnson, Johnson & Johnson MedTech, Johnson and Johnson, Shockwave Medical

FDA authorizes first-of-its-kind autonomous robotic blood draw device

August 21, 2026 By Skyler Rivera

The FDA granted de novo classification to a standalone robotic device that can draw blood from a patient’s arm without a hands-on operator. Dutch medical robotics company Vitestro developed the autonomous robotic phlebotomy device, called Aletta, to conduct every step of a blood draw, “from placing the tourniquet to applying the bandage,” the company says. […]

Filed Under: Biotech, Business/Financial News, Clinical Trials, Digital Health, Featured, Food & Drug Administration (FDA), Healthcare Reform, Lab Instruments & Supplies, Regulatory/Compliance, Robotic-Assisted, Vascular Tagged With: De Novo Clearance, FDA, Robotic Systems, Vitestro

Siemens Healthineers wins $31 million in ARPA-H funding to develop remote robotic stroke treatment

August 21, 2026 By Skyler Rivera

Research Projects Agency for Health (ARPA-H) awarded Siemens Healthineers up to $31.1 million over five years to accelerate development of autonomous remote endovascular robotics, the German medtech giant announced this week. Siemens Healthineers is developing technology for long-distance remote treatment of acute ischemic stroke by mechanical thrombectomy without direct human input. The system will utilize […]

Filed Under: Business/Financial News, Featured, Imaging, Research & Development, Robotic-Assisted, Surgical, Surgical Robotics, Vascular Tagged With: remote robotic surgery, Siemens Healthineers, Stroke, Stryker, surgical robotic platforms, surgical robotics, surgical robots

  • Page 1
  • Page 2
  • Page 3
  • Interim pages omitted …
  • Page 145
  • Go to Next Page »

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >
MDO ad
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2026 · Arrowfly LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of Arrowfly.

Privacy Policy